DE3650689T2 - Rekombinantes inhibin - Google Patents

Rekombinantes inhibin

Info

Publication number
DE3650689T2
DE3650689T2 DE3650689T DE3650689T DE3650689T2 DE 3650689 T2 DE3650689 T2 DE 3650689T2 DE 3650689 T DE3650689 T DE 3650689T DE 3650689 T DE3650689 T DE 3650689T DE 3650689 T2 DE3650689 T2 DE 3650689T2
Authority
DE
Germany
Prior art keywords
recombinant inhibin
inhibin
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3650689T
Other languages
English (en)
Other versions
DE3650689D1 (de
Inventor
Robert Forage
Andrew Stewart
David Mark Milne-Robertson
Kretzer David Moritz De
John Kerr Findlay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash Medical Centre
St Vincents Institute of Medical Research
Biotech Australia Pty Ltd
Monash University
Original Assignee
Monash Medical Centre
St Vincents Institute of Medical Research
Biotech Australia Pty Ltd
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27507359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3650689(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monash Medical Centre, St Vincents Institute of Medical Research, Biotech Australia Pty Ltd, Monash University filed Critical Monash Medical Centre
Application granted granted Critical
Publication of DE3650689D1 publication Critical patent/DE3650689D1/de
Publication of DE3650689T2 publication Critical patent/DE3650689T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3650689T 1985-04-18 1986-04-14 Rekombinantes inhibin Expired - Lifetime DE3650689T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPH019485 1985-04-18
AUPH232085 1985-09-06
AUPH315785 1985-10-29
AUPH396085 1985-12-19
AUPH396185 1985-12-20
PCT/AU1986/000097 WO1986006076A1 (en) 1985-04-18 1986-04-14 Recombinant inhibin

Publications (2)

Publication Number Publication Date
DE3650689D1 DE3650689D1 (de) 1998-08-20
DE3650689T2 true DE3650689T2 (de) 1999-04-08

Family

ID=27507359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3650689T Expired - Lifetime DE3650689T2 (de) 1985-04-18 1986-04-14 Rekombinantes inhibin

Country Status (11)

Country Link
US (1) US6613891B1 (de)
EP (1) EP0218717B1 (de)
JP (1) JP3213470B2 (de)
KR (1) KR940004077B1 (de)
CA (1) CA1341619C (de)
DE (1) DE3650689T2 (de)
DK (1) DK173446B1 (de)
IL (1) IL78519A (de)
IN (1) IN165453B (de)
NZ (1) NZ215829A (de)
WO (1) WO1986006076A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
CA1307736C (en) * 1986-03-13 1992-09-22 David Mark Robertson Method of assay of inhibin
WO1988000208A1 (en) * 1986-06-24 1988-01-14 The Salk Institute For Biological Studies Ovine inhibin
US5196192A (en) * 1988-05-31 1993-03-23 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
US5716789A (en) 1993-07-26 1998-02-10 Cor Therapeutics, Inc. Method to determine ligands, agonist and antagonist of C140 receptor
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU8579298A (en) * 1997-07-31 1999-02-22 Johns Hopkins University School Of Medicine, The Growth differentiation factor-16
US6787311B1 (en) 1999-02-25 2004-09-07 Auckland Uniservices Limited Diagnosis of premature ovarian failure
ES2357321T3 (es) * 2001-04-13 2011-04-25 Boyce Thompson Institute For Plant Research Procedimiento y composiciones para productos farmacéuticos de plantas transgénicas estables y su utilización como anticonceptivos.
CN102409065B (zh) * 2011-06-28 2014-05-21 中国农业科学院北京畜牧兽医研究所 一种提高动物繁育力的新型shRNA及其应用
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
CN105296493B (zh) * 2015-11-13 2020-09-11 北京农学院 一种牛抑制素α亚基成熟肽基因及重组表达蛋白质的方法
CN108588100B (zh) * 2018-05-09 2021-07-16 广州市达瑞生物技术股份有限公司 一种抑制素b双基因片段联合表达载体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4717666A (en) 1984-03-05 1988-01-05 Smithkline Beckman Corporation Cloned streptomycete lividans excretable β-galactosidase gene
BR8406940A (pt) 1983-06-20 1985-06-04 Battelle Development Corp Processo a leito fluidizado com multiplos solidos de alta velocidade
US4643969A (en) 1983-07-25 1987-02-17 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
DE3587022T2 (de) * 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JPH0730114B2 (ja) * 1985-04-03 1995-04-05 正雄 五十嵐 インヒビン
US4624944A (en) 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4737578A (en) 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices

Also Published As

Publication number Publication date
IN165453B (de) 1989-10-21
EP0218717A4 (de) 1990-04-10
DK611386A (da) 1987-02-18
IL78519A (en) 1992-01-15
DE3650689D1 (de) 1998-08-20
IL78519A0 (en) 1986-08-31
JP3213470B2 (ja) 2001-10-02
KR870700633A (ko) 1987-12-30
US6613891B1 (en) 2003-09-02
JPH07188296A (ja) 1995-07-25
EP0218717B1 (de) 1998-07-15
WO1986006076A1 (en) 1986-10-23
DK611386D0 (da) 1986-12-18
KR940004077B1 (ko) 1994-05-11
CA1341619C (en) 2011-08-02
NZ215829A (en) 1991-11-26
DK173446B1 (da) 2000-11-06
EP0218717A1 (de) 1987-04-22

Similar Documents

Publication Publication Date Title
DK153042C (da) Kaeledyrsfoder
DE3650689T2 (de) Rekombinantes inhibin
DK325886A (da) Raerkobling
DK550786D0 (da) 5-phenyl-2-oxazol-derivater
ES291905Y (es) Muneco animable
ATA155686A (de) Giesspfannenkopf
AT386920B (de) Maishaecksler
ATA122686A (de) Kettenschloss
KR860010108U (ko) 다이오우드
ATA173385A (de) Stiegenlift
ATA257585A (de) Ru-deruebungsgeraet
DK528185D0 (da) Peptider
DK467785D0 (da) Peptider
DK411686D0 (da) Peptider
DK395685D0 (da) Peptider
ES290791Y (es) Juguete-reclamo aereo
BE903210A (fr) Gripneiges
BR6501802U (pt) Mini-luminaria
ATA8786A (de) Heukran
SE8500650D0 (sv) Sekerhetslas
BR6500852U (pt) Churrasqueira-espeto
BR6500027U (pt) Conzeiro
BR6500176U (pt) Pulverizador-cobridor
BR6500257U (pt) Chaveiro-calendario-utilidades
BR6500432U (pt) Polainas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition